As of 10:10:02 AM EDT. Market Open. Teva Hong Kong ("Teva"), has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network Ltd ("KLN"). Leveraging Kerry Pharma ...

Beyond logos, create business cards, social media kits, favicons, and more. Download high-resolution PNG, JPEG, and vector files, and get brand guidelines for fonts and colors. Make unlimited changes ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Teva (TEVA) Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries, and Medincell announced that the supplemental New Drug Application for Uzedy extended-release injectable suspension ...

The strategic collaboration between Teva and Alvotech, initiated in August 2020, focused on the exclusive commercialisation of five biosimilar product candidates of the latter. Credit: Igal ...

Teva and Alvotech's Selarsdi, like Stelara, is approved for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and moderately to severely active Crohn's disease and ...

The landing page revealed the As Ever logo, which PEOPLE understands is a tribute to Prince Harry. The logo incorporates a palm tree as a nod to the Duke and Duchess’s home in California ...

Is it the smoothness of running shoes or the convenience of your favourite gym shorts? Or maybe those famous logos let you know at a glance which brand you’re dealing with. In athletic apparel, logos ...

Meghan Markle recently unveiled her rebranded lifestyle brand, As Ever, and its new logo is packed with subtle nods to her family and personal history. The design features a palm tree encased by ...

Meghan's forthcoming lifestyle brand, As Ever, replaces American Riviera Orchard, and its logo features some symbolic details – one of which could be a tribute to Prince Harry's late grandmother ...

Alvotech (NASDAQ:ALVO) and Teva Pharmaceuticals (NYSE:TEVA) said on Tuesday that the U.S. FDA has accepted for review a Biologics License Application for a biosimilar targeting Regeneron’s (REGN ...